TSBX

Turnstone Biologics
TSBX

Delisted

TSBX was delisted on the 8th of August, 2025.

36 hedge funds and large institutions have $33.1M invested in Turnstone Biologics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.53%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
3
Increased
13
Reduced
9
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
UBS Group
26
UBS Group
Switzerland
$18.3K +$14.8K +5,800 +423%
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
$10.7K
TRCT
28
Tower Research Capital (TRC)
New York
$9.65K +$8.43K +3,311 +691%
AIG
29
American International Group
New York
$8.34K +$204 +80 +3%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$7K +$3.84K +1,441 +122%
Wells Fargo
31
Wells Fargo
California
$4.8K +$1.12K +439 +30%
AB
32
Amalgamated Bank
New York
$3K -$164 -61 -5%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$2.76K -$835 -328 -23%
Citigroup
34
Citigroup
New York
$2.59K -$16.6K -6,507 -86%
Legal & General Group
35
Legal & General Group
United Kingdom
$2.03K
AIP
36
Ameritas Investment Partners
Nebraska
$1.6K
Two Sigma Investments
37
Two Sigma Investments
New York
-$171K -43,500 Closed
Millennium Management
38
Millennium Management
New York
-$77.8K -19,744 Closed